AstraZeneca vaccine benefits increase with age: EMA
The EU’s drug watchdog said Friday that a review of AstraZeneca’s COVID-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.
by ·
The EU’s drug watchdog said Friday that a review of AstraZeneca’s COVID-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.
by · Published May 13, 2021
by · Published May 19, 2021
by · Published June 9, 2021